The cost of orphan drugs, and whether it is approaching a level where sustainability may be an issue, is a topic of intense interest in the rare disease community. However, an important new study reported at the recent American Society of Hematology meeting suggests that the overall budget impact of orphan drugs may be smaller than many people would assume. read more >
ESPN anchor Stuart Scott passed away last night at just 49 years old after his 7-plus year battle with appendix cancer. Mostly Scott’s passing makes me feel for his daughters, his family, his friends, and his colleagues. This is their time to reflect and remember him. However, I also think that his public presence makes it seem like we all knew him, and I think he taught us all something by how he handled his illness.
I didn’t know Stuart Scott. But I feel a special kinship with him because the broad outlines of his story and mine are remarkably similar. We were both diagnosed with appendix cancer in November 2007 – I went to the ER on the Friday after Thanksgiving and he had an emergency appendectomy the following Monday (while I was still in the hospital being diagnosed). We both had two recurrences – mine in 2009 and 2010, and his in 2011 and 2013, with multiple major surgeries as our rewards. We both went to work while our bodies absorbed incredible amounts of energy-depriving chemotherapy. We both fought with everything we had to live for our kids. So I didn’t know Stuart Scott, but I know something about what he went through in fighting appendix cancer.
By Lisa Phelps, NORD Director of Marketing & Community Relations
With every New Year comes the resolve of individuals to better themselves in one or more ways. But after the ball has dropped and the confetti is swept away, it’s difficult for 75% of people to remain committed to their resolutions beyond the first week!
This year, consider a resolution to which you can remain committed: Resolve to better the lives (and chance at life) for 30 million individuals – not just one.
Rare Disease Day is only eight weeks after New Year’s Day, falling on February 28, 2015. On this one-of-a-kind day, communities around the world will gather together to raise awareness among the general public and decision-makers about the 7,000+ rare diseases and their impact on the lives of patients. Started by EURORDIS and brought to the US by NORD in 2009, this pivotal day has contributed to national plans and policies to better the lives of patients in over 80 countries.
The New Year’s Resolution: Become a Rare Disease Day Partner and join the 30 million Americans impacted by a rare disease to help patients, caregivers, and organizations working to advance the availability and delivery of information, research, education, treatment and care.
1. You Can Donate to support events and activities by patients and advocates
2. You Can Help Host a State House Event, or join one already in planning
3. You Can Share the Rare Disease Day Message with friends and decision-makers through social media, media/press, or in writing to your elected official
4. You Can Submit a Handprints Across America™ photo – using either your photo, or, if you’re feeling ambitious, find influential public figures to take a photo with the Handprints Across America™ handout! The most influential photo will be included in NORD’s 2015 media campaign with a story on the individual or group that submitted.
Let’s Achieve Our New Year’s Goals Together.
“Alone We Are Rare. Together We Are Strong.”™
If you have supported NORD with a donation at any time during its 31+ year history, we thank you. The wonderful work that NORD has accomplished since 1983 on behalf of rare disease patients and their families wouldn’t have been possible without the support of many caring individuals.
NORD works very hard to be a careful steward of donated funds, keeping operating costs low so that 95 cents of every dollar goes directly to programs and services for patients.
We know that you receive many solicitations for contributions at this time of year, but we believe that NORD has earned a place at the top of your list through its history of dedicated leadership and service.
And we are excited to tell you about two unique opportunities to drive progress for patients in 2015: promoting state-based advocacy through NORD’s Rare Action Network™ (RAN) and advancing research with an innovative new platform NORD has developed for patient registries and natural history studies. read more >
Alena Galan is a happy 16-year old girl full of life and wise beyond her years. She can light up a room with her quick-witted charm and energetic personality. She loves to sing, dance, play guitar and violin, and like most teenagers, enjoys spending time with friends. Alena has a deep-rooted appreciation of life and cherishes every moment – all with good reason.
On January 24, 2002 Dr. Robert Marion, director of Children’s Evaluation & Research Center, Albert Einstein College of Medicine diagnosed Alena with mucopolysaccharidoses VI (MPS VI) or Maroteaux-Lamy syndrome, a rare inherited lysosomal storage disorder. Individuals with MPS VI do not produce the enzyme that carries all the impurities out of their body. This causes thickening of the bones, breathing difficulties, and ceases normal human growth and development. Symptoms gradually worsen over time, and individuals with MPS VI usually do not survive past 25-years old.
The news devastated Marcia Galan, who adopted three-year old Alena from a Russian orphanage just seven weeks earlier. At the time, Alena – who remarkably resembled Marcia – seemed to be healthy and happy. They immediately bonded as mother and daughter. Shortly after bringing Alena home to the U.S., a pediatrician who specializes in Russian adoptees observed several abnormalities, including a heart murmur, which led to further evaluations and the MPS VI diagnosis. read more >
RareDisease Dialog is the official blog for the National Organization for Rare Disorders (NORD). NORD’s staff and friends will share information of interest to the entire rare disease community.
Translate This page:
SUBSCRIBE TO OUR E-NEWS